Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Malesker

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Pharmacotherapy|January 30, 2008
Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbiditiesMark A Malesker
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|October 31, 2022
Drug Interactions Associated With Therapies for Pulmonary Arterial HypertensionShraddha Narechania, Mark A Malesker
Clinical Medicine Insights. Cardiology|February 12, 2014
Potential benefits of icosapent ethyl on the lipid profile: case studiesDaniel E Hilleman, Mark A Malesker
Journal of Critical Care|February 4, 2012
Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patientsMark A Malesker, Daniel E Hilleman
Chest|November 8, 2012
Monitoring immunosuppressive medications for lung disease and lung transplantation: the time is nowMark A Malesker, Lee E Morrow
Managed Care (Langhorne, Pa.)|August 3, 2010
Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapyMark A Malesker, Daniel E Hilleman
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|April 5, 2012
Probiotics in the intensive care unitLee E Morrow, Vijaya Gogineni, Mark A Malesker
Current Opinion in Clinical Nutrition and Metabolic Care|January 18, 2012
Synbiotics and probiotics in the critically ill after the PROPATRIA trialLee E Morrow, Vijaya Gogineni, Mark A Malesker
Current Opinion in Critical Care|February 21, 2012
Probiotic, prebiotic, and synbiotic use in critically ill patientsLee E Morrow, Vijaya Gogineni, Mark A Malesker
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 5, 2021
Management of patients with fibrosing interstitial lung diseasesLee E Morrow, Daniel Hilleman, Mark A Malesker
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Pharmacotherapy|January 30, 2008
Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbiditiesMark A Malesker
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|October 31, 2022
Drug Interactions Associated With Therapies for Pulmonary Arterial HypertensionShraddha Narechania, Mark A Malesker
Clinical Medicine Insights. Cardiology|February 12, 2014
Potential benefits of icosapent ethyl on the lipid profile: case studiesDaniel E Hilleman, Mark A Malesker
Journal of Critical Care|February 4, 2012
Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patientsMark A Malesker, Daniel E Hilleman
Chest|November 8, 2012
Monitoring immunosuppressive medications for lung disease and lung transplantation: the time is nowMark A Malesker, Lee E Morrow
Managed Care (Langhorne, Pa.)|August 3, 2010
Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapyMark A Malesker, Daniel E Hilleman
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|April 5, 2012
Probiotics in the intensive care unitLee E Morrow, Vijaya Gogineni, Mark A Malesker
Current Opinion in Clinical Nutrition and Metabolic Care|January 18, 2012
Synbiotics and probiotics in the critically ill after the PROPATRIA trialLee E Morrow, Vijaya Gogineni, Mark A Malesker
Current Opinion in Critical Care|February 21, 2012
Probiotic, prebiotic, and synbiotic use in critically ill patientsLee E Morrow, Vijaya Gogineni, Mark A Malesker
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 5, 2021
Management of patients with fibrosing interstitial lung diseasesLee E Morrow, Daniel Hilleman, Mark A Malesker
Pageof 5